293 related articles for article (PubMed ID: 2161578)
41. Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer.
Johansson CJ; Gunnarsson PO
Prostate; 2000 Jun; 44(1):26-30. PubMed ID: 10861754
[TBL] [Abstract][Full Text] [Related]
42. Adrenocortical function in old age: response to acute adrenocorticotropin stimulation.
Vermeulen A; Deslypere JP; Schelfhout W; Verdonck L; Rubens R
J Clin Endocrinol Metab; 1982 Jan; 54(1):187-91. PubMed ID: 6274897
[TBL] [Abstract][Full Text] [Related]
43. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
Aro J
Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
[TBL] [Abstract][Full Text] [Related]
44. Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight, and sampling time.
Azziz R; Bradley E; Huth J; Boots LR; Parker CR; Zacur HA
J Clin Endocrinol Metab; 1990 May; 70(5):1273-9. PubMed ID: 2139878
[TBL] [Abstract][Full Text] [Related]
45. Effect of androgen on adrenal steroidogenesis in normal women.
Vermesh M; Silva PD; Rosen GF; Vijod AG; Lobo RA
J Clin Endocrinol Metab; 1988 Jan; 66(1):128-30. PubMed ID: 2826523
[TBL] [Abstract][Full Text] [Related]
46. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
Lindstedt E
Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
[TBL] [Abstract][Full Text] [Related]
47. Steroid-sensitive proteins, growth hormone and somatomedin C in prostatic cancer: effects of parenteral and oral estrogen therapy.
Stege R; Fröhlander N; Carlström K; Pousette A; von Schoultz B
Prostate; 1987; 10(4):333-8. PubMed ID: 2440014
[TBL] [Abstract][Full Text] [Related]
48. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
49. Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal women.
Helgason S; Carlström K; Damber MG; Damber JE; Selstam G; von Schoultz B
Maturitas; 1981 Dec; 3(3-4):301-8. PubMed ID: 6278266
[TBL] [Abstract][Full Text] [Related]
50. Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen.
Henriksson P; Carlström K; Pousette A; Gunnarsson PO; Johansson CJ; Eriksson B; Altersgård-Brorsson AK; Nordle O; Stege R
Prostate; 1999 Jul; 40(2):76-82. PubMed ID: 10386467
[TBL] [Abstract][Full Text] [Related]
51. Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery.
Winterer J; Gwirtsman HE; George DT; Kaye WH; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1985 Oct; 61(4):693-7. PubMed ID: 2993344
[TBL] [Abstract][Full Text] [Related]
52. Estrogen Regulation of Fetal Adrenal Cortical Zone-Specific Development in the Nonhuman Primate Impacts Adrenal Production of Androgen and Cortisol and Response to ACTH in Females in Adulthood.
Pepe GJ; Maniu A; Aberdeen G; Lynch TJ; Albrecht ED
Endocrinology; 2016 May; 157(5):1905-13. PubMed ID: 26990066
[TBL] [Abstract][Full Text] [Related]
53. Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.
Haapiainen R; Rannikko S; Ruutu M; Ala-Opas M; Hansson E; Juusela H; Permi J; Saarialho M; Viitanen J; Alfthan O
Br J Urol; 1991 Feb; 67(2):184-7. PubMed ID: 2004233
[TBL] [Abstract][Full Text] [Related]
54. [Plasma DHA, DHAS and cortisol levels after injection of beta 1-24 corticotrophin beta 1-24 ACTH in normal adult women (author's transl)].
Conte-Devolx B; Oliver C; Verine A; Codaccioni JL; Boyer J
Ann Endocrinol (Paris); 1981; 42(1):43-8. PubMed ID: 6274243
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
Bélanger A; Dupont A; Labrie F
J Clin Endocrinol Metab; 1984 Sep; 59(3):422-6. PubMed ID: 6086697
[TBL] [Abstract][Full Text] [Related]
56. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
Levine AC; Mitty HA; Gabrilove JL
J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism.
Rosenthal KL; Peterson ME
J Am Vet Med Assoc; 1996 Sep; 209(6):1097-102. PubMed ID: 8800255
[TBL] [Abstract][Full Text] [Related]
58. Adrenal function under long-term raloxifene administration.
Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
[TBL] [Abstract][Full Text] [Related]
59. Effects of estrogens on adrenal 3 beta-hydroxysteroid dehydrogenase in ovariectomized women.
Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Sep; 43(3):561-70. PubMed ID: 182711
[TBL] [Abstract][Full Text] [Related]
60. Adrenal hyperresponsiveness to ACTH stimulation in women with polycystic ovary syndrome: an adrenarchal type of response.
Anapliotou MG; Syrigos K; Papanicolaou T; Panayiotakopoulos G; Kalos A; Batrinos ML
Int J Fertil; 1990; 35(4):230-9. PubMed ID: 1977716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
